Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hoekman

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancerA H G Hansma, H J Broxterman, I van der Horst, et al.
British Journal of Cancer|March 4, 1998
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancerA H Honkoop, P J van Diest, J S de Jong, et al.
Journal of Clinical Pathology|April 29, 2004
A patient with a VEGF and endostatin producing gastrointestinal autonomic nerve tumourA H G Hansma, Y van Hensbergen, B C Kuenen, et al.
British Journal of Cancer|March 20, 2003
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivityM de Bruin, T van Capel, K Van der Born, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1996
IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancerA C Ogilvie, C E Hack, J Wagstaff, et al.
British Journal of Cancer|November 1, 1993
Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumoursM W Dercksen, K Hoekman, W W ten Bokkel Huinink, et al.
British Journal of Cancer|January 1, 1997
Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stainH J Broxterman, G J Schuurhuis, J Lankelma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416B C Kuenen, M Levi, J C M Meijers, et al.
American Journal of Clinical Oncology|July 28, 2001
Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumorsJ Van den Brande, V R Nannan Panday, K Hoekman, et al.
International Journal of Cancer|May 29, 1997
Expression of drug resistance proteins in breast cancer, in relation to chemotherapyS C Linn, H M Pinedo, J van Ark-Otte, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancerA H G Hansma, H J Broxterman, I van der Horst, et al.
British Journal of Cancer|March 4, 1998
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancerA H Honkoop, P J van Diest, J S de Jong, et al.
Journal of Clinical Pathology|April 29, 2004
A patient with a VEGF and endostatin producing gastrointestinal autonomic nerve tumourA H G Hansma, Y van Hensbergen, B C Kuenen, et al.
British Journal of Cancer|March 20, 2003
Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivityM de Bruin, T van Capel, K Van der Born, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1996
IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancerA C Ogilvie, C E Hack, J Wagstaff, et al.
British Journal of Cancer|November 1, 1993
Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumoursM W Dercksen, K Hoekman, W W ten Bokkel Huinink, et al.
British Journal of Cancer|January 1, 1997
Highly sensitive and specific detection of P-glycoprotein function for haematological and solid tumour cells using a novel nucleic acid stainH J Broxterman, G J Schuurhuis, J Lankelma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2003
Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416B C Kuenen, M Levi, J C M Meijers, et al.
American Journal of Clinical Oncology|July 28, 2001
Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumorsJ Van den Brande, V R Nannan Panday, K Hoekman, et al.
International Journal of Cancer|May 29, 1997
Expression of drug resistance proteins in breast cancer, in relation to chemotherapyS C Linn, H M Pinedo, J van Ark-Otte, et al.
Pageof 7